Annis Gardner Whiting Capital Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,753
Closed -$182K 504
2026
Q1
$182K Buy
+1,753
New +$199K 0.03% 320
2025
Q4
Sell
-100
Closed -$12.3K 1234
2025
Q3
$12.3K Sell
100
-56
-36% -$6.95K ﹤0.01% 678
2025
Q2
$18.7K Hold
156
0.01% 581
2025
Q1
$23K Hold
156
0.01% 436
2024
Q4
$25.3K Hold
156
0.01% 413
2024
Q3
$25.4K Hold
156
0.01% 435
2024
Q2
$21.3K Hold
156
0.01% 556
2024
Q1
$23.9K Hold
156
0.01% 516
2023
Q4
$22.2K Hold
156
0.01% 385
2023
Q3
$20.4K Buy
+156
New +$23.7K 0.01% 383

Other funds holding CLX

Annis Gardner Whiting Capital Advisors's CLX Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Clorox (CLX) in Q2 2026, closing a stake of 1,753 shares — an estimated $182K sold.

Annis Gardner Whiting Capital Advisors first reported a position in CLX in Q3 2023 and held it in 10 quarters. The position peaked at $182K in Q1 2026. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 1,753 Clorox shares in Q2 2026, an estimated $182K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Clorox in Q3 2023 and held it in 10 quarters.
  • Annis Gardner Whiting Capital Advisors's Clorox position peaked at $182K in Q1 2026.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.